Advertisement

Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px
Financing › Details

Mologen–SEVERAL: investment, 200903 capital increase €2.8m 425k new shares €6.5/share to institutional investors

 

Period Period 2009-03-27
  Successor Mologen–SEVERAL: investment, 200912–201001 capital increase €3.58m 512k new shares €7/share to institutional investors
Organisations Money taker Mologen AG
  Group Mologen (Group)
  Money source INSTITUTIONAL INVESTORS
  Group OTHER
Products Product cancer drug
  Product 2 therapeutic vaccine
     

   
Record changed: 2017-04-02

Advertisement

Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 650x65px

More documents for Mologen (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture EBD Group BIO-Europe Spring 2020 Paris BEU2020 650x75




» top